Company Filing History:
33 out of 2,656 
11 out of 3,435 
2 out of 30 
Years Active: 1993-2023
Title: Mark Stanley Cushman: Innovator in Delta-opioid Receptor Agonists
Introduction:
In the world of pharmaceutical innovations, Mark Stanley Cushman has made significant contributions through his research and development of novel δ-opioid receptor agonists. Based in West Lafayette, IN (US), Cushman is a highly accomplished inventor with an impressive portfolio of 37 patents to his name. Let us delve deeper into his latest patents, career highlights, and collaborations.
Latest Patents:
Cushman's latest patents revolve around the field of δ-opioid receptor agonists. These novel compounds are selective agonists, designed specifically to have minimal or no beta-arrestin 2 recruitment. These unique compounds show potential in the treatment of alcohol use disorders and other co-occurring psychiatric disorders. Cushman's work in this area is a testament to his dedication and expertise in developing innovative solutions for complex medical conditions.
Career Highlights:
Mark Stanley Cushman has worked with renowned organizations in his career, including the Purdue Research Foundation and the United States of America, as represented by the Secretary, Department of Health and Human Services. His extensive experience in these institutions has provided him with the platform to conduct groundbreaking research and develop novel pharmaceutical agents.
Collaborations:
Throughout his career, Cushman has collaborated with esteemed professionals in his field. Notable among his co-workers are Yves Pommier and Andrew E Morrell, who have contributed to Cushman's research and the development of delta-opioid receptor agonists. Their combined expertise and dedication have undoubtedly advanced the field of pharmaceutical innovation.
Conclusion:
With a remarkable portfolio of 37 patents and a focus on developing novel delta-opioid receptor agonists, Mark Stanley Cushman has demonstrated his commitment to advancing the field of pharmaceutical innovation. His work in this specialized area has potential applications in the treatment of alcohol use disorders and co-occurring psychiatric disorders, offering new hope for patients in need. Cushman's collaborations with esteemed professionals further highlight his ability to work effectively as part of a team. As a valued contributor to the field, Mark Stanley Cushman continues to make significant strides in the development of innovative solutions in pharmacology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.